| Issue Date | Title | Author(s) |
| 2025 | Autoimmune Thyroiditis and Its Impact on the Clinical Course of Multiple Sclerosis: a Retrospective Cohort Study | Kaya, Ergi; Samadzade, Ulvi; Zengin, Ela Simay; Ozakbas, Serkan |
| 2024 | Comparison of the Objective and Subjective Cognitive Fatigue During Relapse and Remission in Individuals With Multiple Sclerosis: Preliminary Results | Ozakbas, Serkan ; Yigit, Pinar; Kara, Irem; Samadzade, Ulvi; Ozdogar, Asiye Tuba |
| 2024 | Determinants of Postpartum Relapse in Multiple Sclerosis: a Comprehensive Analysis of Demographic and Clinical Factors | Alizada, Said; Samadzade, Ulvi; Yapici, Nurbanu; Kaya, Ergi; Ozdogar, Asiye Tuba; Ozakbas, Serkan |
| 2024 | Epilepsy Prevalence and Characteristics in Patients with Multiple Sclerosis: Implications for Disease Management | Kaya, Ergi; Samadzade, Ulvi; Unal, Gozde Deniz; Zengin, Ela; Ozakbas, Serkan |
| 2024 | Impact of Diagnosis and Treatment Timing on Long-Term Outcomes in Multiple Sclerosis: A Comprehensive Study | Ozakbas, Serkan ; Samadzade, Ulvi; Kara, Irem; Unal, Gozde Deniz |
| 2024 | Impact of Early Treatment Modification on Long-Term Outcomes in Treatment-Naive Multiple Sclerosis Patients: Adverse Reactions and Compliance Challenges | Samadzade, Ulvi; Baba, Cavid; Simsek, Yasemin; Unal, Gozde Deniz; Kara, Irem; Ertekin, Ozge; Ozakbas, Serkan |
| 2024 | Natalizumab Treatment Outcomes and Safety Profile in Women With Multiple Sclerosis: Insights From Real-World Data | Simsek, Yasemin; Abasiyanik, Zuhal; Samadzade, Ulvi; Ozakbas, Serkan |
| 2024 | The Oligoclonal Band Dilemma: Decoding Its Role in Predicting Relapsing-Remitting Multiple Sclerosis Progression | Baba, Cavid; Alizada, Said; Samadzade, Ulvi; Cevik, Sumeyye; Yapici, Nurbanu; Simsek, Yasemin; Ozakbas, Serkan |
